Skip to content

ADAR1 Capital Management, LLC, 10% owner at InMed Pharmaceuticals, bought INM on Oct 5, 2026

Data as of Oct 16

▲ BUY$24.2K18,182 shares at $1.33ADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.
Watch INM
Traded
Oct 5, 2026
Disclosed
Oct 5, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

ADAR1 Capital Management, LLC, 10% owner at InMed Pharmaceuticals, bought INM on Oct 5, 2026TRADEDDISCLOSED
INMSimilar stocks (XLV — its sector index fund), rebased to INM's price on the disclosure day
INM since disclosure
−0.8%
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$24.2Kdisclosed Oct 5 · filed the same day
  2. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$11Kdisclosed Oct 5 · filed 3 days after the trade
  3. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$11Kdisclosed Oct 5 · filed 3 days after the trade
  4. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$21.9Kdisclosed Oct 5 · filed 4 days after the trade
  5. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$21.9Kdisclosed Oct 5 · filed 4 days after the trade

See every trade on INM →